Athletic boost? A year after starting hormone treatments, transgender women still have an advantage over cisgender peers

Dr Rachel McKinnon (center) became the first transgender track world champion. Credit: McKinnon
Dr Rachel McKinnon (center) became the first transgender track world champion. Credit: McKinnon

A new study suggests transgender women maintain an athletic advantage over their cisgender peers even after a year on hormone therapy.

The results, published [November 6] in the British Journal of Sports Medicine, could mean the current one-year waiting period for Olympic athletes who are transitioning is inadequate.

“For the Olympic level, the elite level, I’d say probably two years is more realistic than one year,” said the study’s lead author, Dr. Timothy Roberts, a pediatrician and the director of the adolescent medicine training program at Children’s Mercy Hospital in Kansas City, Missouri. “At one year, the trans women on average still have an advantage over the cis women,” he said, referring to cisgender, or nontransgender, women.

Related article:  98: That's how many humans it would take to start over on another planet
Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.
[Medical physicist and transgender runner Joanna] Harper, who was a consultant on the IOC’s current recommendations, said the real takeaway from Roberts’ study is that transgender women ultimately do reach parity with cis women in athletic tasks. She, however, doesn’t think Roberts’ findings mean sporting organizations need to require two years of testosterone suppression before trans women can compete against cisgender women.

“It’s not necessary for all advantages to be removed,” she said. “All that is necessary is for trans women to perform more like cisgender women than like cisgender men.”

Read the original post

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: How dangerous COVID mutant strains develop

Infographic: How dangerous COVID mutant strains develop

Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...
Untitled

Philip Njemanze: Leading African anti-GMO activist claims Gates Foundation destroying Nigeria

Nigerian anti-GMO activist, physician, and inventor pushes anti-gay and anti-GMO ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend